SlideShare a Scribd company logo
Developed by
Dr.Abdulrazzaq Othman Alagbare-MD-MCP-
Hematology Lecturer
INTRODUCTION
hematological- malignant Disorders
FOR Clinical LABORATORY STUDENTS
The Malignant Hematological Disorders
Means malignancy for all blood cells that produce from the bone marrow
1-Leukemia for the following
cells
a) Neutrophil
b) Eosinophil
c) Basophil
d) Monocyte
e) T-Lymphocyte
f) B-Lymphocyt
2-RBC:
Polycythemia Vera (PV)
3-Thrombocytes : Essential
Thrombocythemia (ET)
4-Plasm cells
Multiple myeloma (MM)
Introduction-Leukemia
Definition: Leukemia is a cancer of blood white cells
Caused by the mutation of
pluripotent or most
primitive stem cells. (PSC,
MSC, LSC)
Blast cells accumulate in the Bone
marrow and
1. peripheral blood
2. Spleen
3. Lymph nodes
4. Liver
The leukemic cells are
1. Trapped early from the B.M
2. Proliferate without control (No effect of growth factors)
3. Not able to carry out their function
4. fetal disease if not treated
1
1- Myeloid group malignancies
Granullar cells ––> (N. E. and B ) Leukemias
Monocytes ––> Monocytic leukemia
Erythrocytes ––> Polycythemia vera
Platelets ––> Essential thrombocythemia
2- Lymphoid group malignancies
B-lymphocytes ––> Leukemias
T-lymphocytes ––> Leukemias
Plasma cells ––> Multiple myeloma
Causes of leukemia or Predisposing factors
1. Inherited factors
2. Environmental
factors
3. Infection
genetic diseases e.g.
Down's syndrome,
Klinefelter's syndrome,
Fanconi's anemia,
Chemicals e.g.
Benzene
Drugs e.g.
Alkylating agents
Radiation
Viruses e.g. Epstein-Barr virus EBV, HIV,
Human herpes virus 8 (HHV-8)
Bacteria e.g. Helicobacter Pylori
Protozoa e.g. Malaria
FAB classification
The FAB classification is based largely on.
1-Morphology of cells
2-Simple cytochemical stains
1. At least 30% of cells in the
bone marrow or blood must be
myeloblasts.
2. and does not include cytogenetic
abnormalities
But must be
Differences between acute and chronic leukemia
1- Cells maturation degree (blast or mature )
2-Blood cells count in the peripheral blood
3-Patient`s symptoms
4-Clinical onset
5-organomegaly
6-patient`s age
All Leukemia divided into Acute and chronic
Properties of acute leukemia Properties of chronic leukemia
 Immature cells (90% blast cells )  More mature cells (60%-70% mature cells)
 Occurs in all ages  Usually occurs in adults and elderly
 Clinical onset is sudden  Clinical onset is gradual
 Anemia and thrombocytopenia are severe  Anemia and thrombocytopenia are mild
 WBC is variable (high, normal or low with 90 %
blast cells)
 WBC is increased , abnormal cells, (30% blast )
 organomegaly is mild  Organomegaly is prominent
Clinical Picture of acute
leukemias
Clinical Picture of chronic
leukemias
The patient has
1. Anemia
2. Bleeding
3. Infection
The patient has
1. No anemia
2. No bleeding
3. No Infection
Acute leukemia cause morbidity and mortality through :-
1. Deficiency in blood cell number and function
2. Invasion of vital organs
3. Systemic disturbances by metabolic imbalance
Pathophysiology
Acute leukemia cause morbidity and mortality through :-
1. Deficiency in blood cell number and function
2. Invasion of vital organs
3. Systemic disturbances by metabolic imbalance
Investigations need to diagnose leukemia
1. Complete blood count.(CBC or FBC)
2. Peripheral blood film inspection
3. A bone marrow examination
4. Flow cytometry or immunophenotyping studies
5. Chromosomal analysis
6. Cytochemical stains
1-Complete blood count show
1. The RBC changes
2. WBC: count,
3. Platelets: count and morphology
PBS: show
1. Changes of white blood cells,
2. % of blast cells
3. Type of blast cells (myeloblast or lymphoblast etc)
4. morphologic feature (auer rods, vacuoles , the size of the
nucleus etc)
2-A bone marrow examination
• mostly has hypercellular B.M and few cases hypocellular
• 20% to 90% leukemic blasts at diagnosis or during relapse.
• The blast must present in the peripheral blood, unless the WBC count is markedly
decreased.
Acute leukemia
Bone Marrow Tryphine Biopsy
It is a histological test for bone marrow tissue to obtain the blood cells
Indication: If the peripheral blood indicate
1-hypocelluar
2-aplastic anemia
3-metastic cancer
Or the previous result indicate  Dry tap bone marrow aspiration
3-Flow cytometry or immunophenotypic studies
Monoclonal antibodies toward cell-type restricted antigens are used in this
highly specific method
CD markers Show for
1. blast cells
2. mature cells
and determine if it is
1. myeloid Cells types and count
2. lymphoid cells types and count
3. Normal or abnormal
4- Chromosomal analysis
Chromosomal abnormalities studies is very important (diagnostic
and prognostic ) for
• AML
• ALL
critical in the diagnosis and treatment of AML.As in
ALL
Note
1-AML: Acute myeloblastic Leukemia
2-ALL: Acute Lymphoblastic Leukemia
5-Cytochemical stains
Importance: very helpful in the diagnosis and classification of acute
leukemias
Specimens: bone marrow smears but may also be done on peripheral
smears
1. myeloperoxidase (MPO)
2. Sudan black B stain (SBB)
3. specific esterase stain (SE)
4. a non specific esterase stain (NSE)
5. Terminal deoxynucleotidyl transferase (TdT)
Types
Cytochemical Reaction Cellular Element Stained Blasts Identified
Myeloperoxidase
(MPO)
Neutrophil primary granules Myeloblasts strong positive;
Sudan Black B (SBB) Phospholipids Myeloblasts strong positive;
Specific esterase Cellular enzyme Myeloblasts strong positive;
Nonspecific esterase
(NSE)
Cellular enzyme Monoblasts strong positive
Terminal
deoxynucleotidyl
transferase (TdT)
Intranuclear enzyme Lymphoblasts positive
-Positive-Myeloperoxidase- (MPO)
Brown black deposits
Positive-Chloracetate (Specific) Esterase-Myeloid
Cell Line
Red deposit Brown deposits
Positive-Non-Specific Esterase
Monocytic Line
Leukocyte Alkaline Phosphatase (LAP, Neutrophil Alkaline
Phosphatase, NAP)
Definition: The LAP score is a test done by performing a chemical reaction
on a blood smear
Evaluation:
1. The blood smear is viewed under a microscope, and the degree of granular staining
in mature neutrophils (bands and segs) is graded from 0 (no staining) to 4+ (dense
granular staining).
2. The LAP score is the sum of staining for 100 cells.
3. The normal range is 20 to 100.
Principle: The granular of bands and segs with the alkaline phosphatase
enzyme colored staining.
LAP Score
• Count 100 consecutive segs and
bands
• Score:
0 = no granules
1+ = occasional diffuse granules
2+ = moderate number of granules
3+ = many strongly positive granules
4+ = confluent strongly positive
granules
Example:
0 x 35 cells = 0
1+ x 30 cells = 30
2+ x 20 cells = 40
3+ x 10 cells = 30
4+ x 5 cells = 20
120
LAP Score
0 1+
2+ 3+ 4+
The two main conditions with
a low LAP score are
1. CML
2. paroxysmal nocturnal hemoglobinuria (PNH).
higher scores in
1. Polycythemia vera.
2. Myelofibrosis
3. Essential thrombocytopenia
4. leukemoid reactions
LAP score and related diseases
Precuations
1. Reject specimens collected in EDTA-anticoagulated (lavender-topped) tubes because EDTA inhibits the
activity of LAP
2. Results are invalid if the client is neutropenic (that is, <1000/mm3 neutrophils).
Instrumentation and leukemia
Platelets
The platelets count increased due to fragments of the
leukemic blasts, which are counted as platelets
To solve this problem
1. Platelets must be counted manually
2. Examination of a blood smear gives a more accurate
assessment of the platelet count in this circumstance.
Instrumentation and leukemia
WBC
Must check
1-The count on the blood smear
2-the DLC, if not agree count to 200 cells ,
report the average
Be carful for
1-the clot , old . Lipemic specimen, affects the results of CBC
2-the age of the patient (infant, child, adult) must be taken into account
3- newborns, toddlers, and young children, particular reference ranges must be taken
into account
4- a normal range is given, covering 95% of the values of healthy persons
5-The presence of abnormal cells needs clinical pathologist
END OF THE
LESSON

More Related Content

Similar to Introduction of Hematol.Malignancy .ppt

Lesson 4 chronic myeloid leukemia - CML.ppt
Lesson 4  chronic myeloid leukemia - CML.pptLesson 4  chronic myeloid leukemia - CML.ppt
Lesson 4 chronic myeloid leukemia - CML.ppt
Dr.Abdulrazzak Alagbari
 
Leukemia .pptx
Leukemia                           .pptxLeukemia                           .pptx
Leukemia .pptx
bebebody368
 
AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
chetanpattar7
 
LEUKEMIA BY PRIYANKA.pptx...............
LEUKEMIA BY PRIYANKA.pptx...............LEUKEMIA BY PRIYANKA.pptx...............
LEUKEMIA BY PRIYANKA.pptx...............
drpriyankaganani
 
Leukemias-basic pathology
Leukemias-basic pathologyLeukemias-basic pathology
Leukemias-basic pathology
jaiminmanek4
 
Leukaemia for bds
Leukaemia for bdsLeukaemia for bds
Leukaemia for bds
Sunil Rao
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
Ali Swailmeen
 
Chronic myeloid leukemia genetics гбйт ягш
Chronic myeloid leukemia genetics гбйт ягшChronic myeloid leukemia genetics гбйт ягш
Chronic myeloid leukemia genetics гбйт ягш
ssuser10ca4c
 
leukemias.ppt
leukemias.pptleukemias.ppt
leukemias.ppt
Ismailkhan757863
 
An update of Acute leukemia in children.ppt
An update of Acute leukemia in children.pptAn update of Acute leukemia in children.ppt
An update of Acute leukemia in children.ppt
TareqHasanRana
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Sansar Babu Tiwari
 
White blood cells v5
White blood cells v5White blood cells v5
White blood cells v5
mike_flower
 
acuteleukemias-_1.pptx
acuteleukemias-_1.pptxacuteleukemias-_1.pptx
acuteleukemias-_1.pptx
mulugeta asmamaw
 
Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)
Ahmed Makboul
 
Acute leukemia
Acute leukemiaAcute leukemia
Acute leukemia
yeabkidan wubie
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
Pradip Katwal
 
Childhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptxChildhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptx
NanditaHalder3
 
Childhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptxChildhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptx
NanditaHalder3
 
MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
Manoj Aryal
 
Leukemia
Leukemia Leukemia
Leukemia
Aparna A
 

Similar to Introduction of Hematol.Malignancy .ppt (20)

Lesson 4 chronic myeloid leukemia - CML.ppt
Lesson 4  chronic myeloid leukemia - CML.pptLesson 4  chronic myeloid leukemia - CML.ppt
Lesson 4 chronic myeloid leukemia - CML.ppt
 
Leukemia .pptx
Leukemia                           .pptxLeukemia                           .pptx
Leukemia .pptx
 
AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
 
LEUKEMIA BY PRIYANKA.pptx...............
LEUKEMIA BY PRIYANKA.pptx...............LEUKEMIA BY PRIYANKA.pptx...............
LEUKEMIA BY PRIYANKA.pptx...............
 
Leukemias-basic pathology
Leukemias-basic pathologyLeukemias-basic pathology
Leukemias-basic pathology
 
Leukaemia for bds
Leukaemia for bdsLeukaemia for bds
Leukaemia for bds
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
 
Chronic myeloid leukemia genetics гбйт ягш
Chronic myeloid leukemia genetics гбйт ягшChronic myeloid leukemia genetics гбйт ягш
Chronic myeloid leukemia genetics гбйт ягш
 
leukemias.ppt
leukemias.pptleukemias.ppt
leukemias.ppt
 
An update of Acute leukemia in children.ppt
An update of Acute leukemia in children.pptAn update of Acute leukemia in children.ppt
An update of Acute leukemia in children.ppt
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
White blood cells v5
White blood cells v5White blood cells v5
White blood cells v5
 
acuteleukemias-_1.pptx
acuteleukemias-_1.pptxacuteleukemias-_1.pptx
acuteleukemias-_1.pptx
 
Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)
 
Acute leukemia
Acute leukemiaAcute leukemia
Acute leukemia
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Childhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptxChildhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptx
 
Childhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptxChildhood Acute Leukemia.pptx
Childhood Acute Leukemia.pptx
 
MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
 
Leukemia
Leukemia Leukemia
Leukemia
 

More from Dr.Abdulrazzak Alagbari

Hepatoblastoma-HB.pdf
Hepatoblastoma-HB.pdfHepatoblastoma-HB.pdf
Hepatoblastoma-HB.pdf
Dr.Abdulrazzak Alagbari
 
Genetic terms in blood banking
Genetic terms in blood bankingGenetic terms in blood banking
Genetic terms in blood banking
Dr.Abdulrazzak Alagbari
 
Blood Apheresis technologies.Laboratory Evaluation.pdf
Blood Apheresis technologies.Laboratory Evaluation.pdfBlood Apheresis technologies.Laboratory Evaluation.pdf
Blood Apheresis technologies.Laboratory Evaluation.pdf
Dr.Abdulrazzak Alagbari
 
Childhood hepatocellular carcinoma.pdf
Childhood hepatocellular carcinoma.pdfChildhood hepatocellular carcinoma.pdf
Childhood hepatocellular carcinoma.pdf
Dr.Abdulrazzak Alagbari
 
BLOOD DONATION INFO..pdf
BLOOD DONATION INFO..pdfBLOOD DONATION INFO..pdf
BLOOD DONATION INFO..pdf
Dr.Abdulrazzak Alagbari
 
Pediatric Hepatoblastoma-HB.pdf
Pediatric Hepatoblastoma-HB.pdfPediatric Hepatoblastoma-HB.pdf
Pediatric Hepatoblastoma-HB.pdf
Dr.Abdulrazzak Alagbari
 
Bones Cancers- Ewing`s Sarcoma.pdf
Bones Cancers- Ewing`s Sarcoma.pdfBones Cancers- Ewing`s Sarcoma.pdf
Bones Cancers- Ewing`s Sarcoma.pdf
Dr.Abdulrazzak Alagbari
 
Macrocytic anemia.pdf
Macrocytic anemia.pdfMacrocytic anemia.pdf
Macrocytic anemia.pdf
Dr.Abdulrazzak Alagbari
 
Normocytic Anemias.pdf
Normocytic Anemias.pdfNormocytic Anemias.pdf
Normocytic Anemias.pdf
Dr.Abdulrazzak Alagbari
 
Anemia Classification and Investigation Tests.pdf
Anemia Classification and Investigation Tests.pdfAnemia Classification and Investigation Tests.pdf
Anemia Classification and Investigation Tests.pdf
Dr.Abdulrazzak Alagbari
 
Introduction of anemias.pdf
Introduction of anemias.pdfIntroduction of anemias.pdf
Introduction of anemias.pdf
Dr.Abdulrazzak Alagbari
 
Osteosarcoma.pdf
Osteosarcoma.pdfOsteosarcoma.pdf
Osteosarcoma.pdf
Dr.Abdulrazzak Alagbari
 
Langerhans Cell Histiocytosis (LCH).pdf
Langerhans Cell Histiocytosis (LCH).pdfLangerhans Cell Histiocytosis (LCH).pdf
Langerhans Cell Histiocytosis (LCH).pdf
Dr.Abdulrazzak Alagbari
 
Hodgkin Lymphoma- H.L.pdf
Hodgkin Lymphoma- H.L.pdfHodgkin Lymphoma- H.L.pdf
Hodgkin Lymphoma- H.L.pdf
Dr.Abdulrazzak Alagbari
 
Pediatric Non Hodgkin lymphoma NEW.pdf
Pediatric  Non Hodgkin lymphoma NEW.pdfPediatric  Non Hodgkin lymphoma NEW.pdf
Pediatric Non Hodgkin lymphoma NEW.pdf
Dr.Abdulrazzak Alagbari
 
Qualitative defects of granular white cells.ppt
Qualitative defects of granular white cells.pptQualitative defects of granular white cells.ppt
Qualitative defects of granular white cells.ppt
Dr.Abdulrazzak Alagbari
 
Iron Metabolism .ppt
Iron Metabolism .pptIron Metabolism .ppt
Iron Metabolism .ppt
Dr.Abdulrazzak Alagbari
 
Spleen function and structure.ppt
Spleen function and structure.pptSpleen function and structure.ppt
Spleen function and structure.ppt
Dr.Abdulrazzak Alagbari
 
Red Blood Cells Production- Erythropoiesis.ppt
Red Blood Cells Production- Erythropoiesis.pptRed Blood Cells Production- Erythropoiesis.ppt
Red Blood Cells Production- Erythropoiesis.ppt
Dr.Abdulrazzak Alagbari
 
Lymphopoiesis-.ppt
Lymphopoiesis-.pptLymphopoiesis-.ppt
Lymphopoiesis-.ppt
Dr.Abdulrazzak Alagbari
 

More from Dr.Abdulrazzak Alagbari (20)

Hepatoblastoma-HB.pdf
Hepatoblastoma-HB.pdfHepatoblastoma-HB.pdf
Hepatoblastoma-HB.pdf
 
Genetic terms in blood banking
Genetic terms in blood bankingGenetic terms in blood banking
Genetic terms in blood banking
 
Blood Apheresis technologies.Laboratory Evaluation.pdf
Blood Apheresis technologies.Laboratory Evaluation.pdfBlood Apheresis technologies.Laboratory Evaluation.pdf
Blood Apheresis technologies.Laboratory Evaluation.pdf
 
Childhood hepatocellular carcinoma.pdf
Childhood hepatocellular carcinoma.pdfChildhood hepatocellular carcinoma.pdf
Childhood hepatocellular carcinoma.pdf
 
BLOOD DONATION INFO..pdf
BLOOD DONATION INFO..pdfBLOOD DONATION INFO..pdf
BLOOD DONATION INFO..pdf
 
Pediatric Hepatoblastoma-HB.pdf
Pediatric Hepatoblastoma-HB.pdfPediatric Hepatoblastoma-HB.pdf
Pediatric Hepatoblastoma-HB.pdf
 
Bones Cancers- Ewing`s Sarcoma.pdf
Bones Cancers- Ewing`s Sarcoma.pdfBones Cancers- Ewing`s Sarcoma.pdf
Bones Cancers- Ewing`s Sarcoma.pdf
 
Macrocytic anemia.pdf
Macrocytic anemia.pdfMacrocytic anemia.pdf
Macrocytic anemia.pdf
 
Normocytic Anemias.pdf
Normocytic Anemias.pdfNormocytic Anemias.pdf
Normocytic Anemias.pdf
 
Anemia Classification and Investigation Tests.pdf
Anemia Classification and Investigation Tests.pdfAnemia Classification and Investigation Tests.pdf
Anemia Classification and Investigation Tests.pdf
 
Introduction of anemias.pdf
Introduction of anemias.pdfIntroduction of anemias.pdf
Introduction of anemias.pdf
 
Osteosarcoma.pdf
Osteosarcoma.pdfOsteosarcoma.pdf
Osteosarcoma.pdf
 
Langerhans Cell Histiocytosis (LCH).pdf
Langerhans Cell Histiocytosis (LCH).pdfLangerhans Cell Histiocytosis (LCH).pdf
Langerhans Cell Histiocytosis (LCH).pdf
 
Hodgkin Lymphoma- H.L.pdf
Hodgkin Lymphoma- H.L.pdfHodgkin Lymphoma- H.L.pdf
Hodgkin Lymphoma- H.L.pdf
 
Pediatric Non Hodgkin lymphoma NEW.pdf
Pediatric  Non Hodgkin lymphoma NEW.pdfPediatric  Non Hodgkin lymphoma NEW.pdf
Pediatric Non Hodgkin lymphoma NEW.pdf
 
Qualitative defects of granular white cells.ppt
Qualitative defects of granular white cells.pptQualitative defects of granular white cells.ppt
Qualitative defects of granular white cells.ppt
 
Iron Metabolism .ppt
Iron Metabolism .pptIron Metabolism .ppt
Iron Metabolism .ppt
 
Spleen function and structure.ppt
Spleen function and structure.pptSpleen function and structure.ppt
Spleen function and structure.ppt
 
Red Blood Cells Production- Erythropoiesis.ppt
Red Blood Cells Production- Erythropoiesis.pptRed Blood Cells Production- Erythropoiesis.ppt
Red Blood Cells Production- Erythropoiesis.ppt
 
Lymphopoiesis-.ppt
Lymphopoiesis-.pptLymphopoiesis-.ppt
Lymphopoiesis-.ppt
 

Recently uploaded

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

Introduction of Hematol.Malignancy .ppt

  • 1. Developed by Dr.Abdulrazzaq Othman Alagbare-MD-MCP- Hematology Lecturer INTRODUCTION hematological- malignant Disorders FOR Clinical LABORATORY STUDENTS
  • 2. The Malignant Hematological Disorders Means malignancy for all blood cells that produce from the bone marrow 1-Leukemia for the following cells a) Neutrophil b) Eosinophil c) Basophil d) Monocyte e) T-Lymphocyte f) B-Lymphocyt 2-RBC: Polycythemia Vera (PV) 3-Thrombocytes : Essential Thrombocythemia (ET) 4-Plasm cells Multiple myeloma (MM)
  • 3. Introduction-Leukemia Definition: Leukemia is a cancer of blood white cells Caused by the mutation of pluripotent or most primitive stem cells. (PSC, MSC, LSC) Blast cells accumulate in the Bone marrow and 1. peripheral blood 2. Spleen 3. Lymph nodes 4. Liver The leukemic cells are 1. Trapped early from the B.M 2. Proliferate without control (No effect of growth factors) 3. Not able to carry out their function 4. fetal disease if not treated 1
  • 4. 1- Myeloid group malignancies Granullar cells ––> (N. E. and B ) Leukemias Monocytes ––> Monocytic leukemia Erythrocytes ––> Polycythemia vera Platelets ––> Essential thrombocythemia 2- Lymphoid group malignancies B-lymphocytes ––> Leukemias T-lymphocytes ––> Leukemias Plasma cells ––> Multiple myeloma
  • 5. Causes of leukemia or Predisposing factors 1. Inherited factors 2. Environmental factors 3. Infection genetic diseases e.g. Down's syndrome, Klinefelter's syndrome, Fanconi's anemia, Chemicals e.g. Benzene Drugs e.g. Alkylating agents Radiation Viruses e.g. Epstein-Barr virus EBV, HIV, Human herpes virus 8 (HHV-8) Bacteria e.g. Helicobacter Pylori Protozoa e.g. Malaria
  • 6. FAB classification The FAB classification is based largely on. 1-Morphology of cells 2-Simple cytochemical stains 1. At least 30% of cells in the bone marrow or blood must be myeloblasts. 2. and does not include cytogenetic abnormalities But must be
  • 7. Differences between acute and chronic leukemia 1- Cells maturation degree (blast or mature ) 2-Blood cells count in the peripheral blood 3-Patient`s symptoms 4-Clinical onset 5-organomegaly 6-patient`s age All Leukemia divided into Acute and chronic
  • 8. Properties of acute leukemia Properties of chronic leukemia  Immature cells (90% blast cells )  More mature cells (60%-70% mature cells)  Occurs in all ages  Usually occurs in adults and elderly  Clinical onset is sudden  Clinical onset is gradual  Anemia and thrombocytopenia are severe  Anemia and thrombocytopenia are mild  WBC is variable (high, normal or low with 90 % blast cells)  WBC is increased , abnormal cells, (30% blast )  organomegaly is mild  Organomegaly is prominent
  • 9. Clinical Picture of acute leukemias Clinical Picture of chronic leukemias The patient has 1. Anemia 2. Bleeding 3. Infection The patient has 1. No anemia 2. No bleeding 3. No Infection Acute leukemia cause morbidity and mortality through :- 1. Deficiency in blood cell number and function 2. Invasion of vital organs 3. Systemic disturbances by metabolic imbalance
  • 10. Pathophysiology Acute leukemia cause morbidity and mortality through :- 1. Deficiency in blood cell number and function 2. Invasion of vital organs 3. Systemic disturbances by metabolic imbalance
  • 11. Investigations need to diagnose leukemia 1. Complete blood count.(CBC or FBC) 2. Peripheral blood film inspection 3. A bone marrow examination 4. Flow cytometry or immunophenotyping studies 5. Chromosomal analysis 6. Cytochemical stains
  • 12. 1-Complete blood count show 1. The RBC changes 2. WBC: count, 3. Platelets: count and morphology PBS: show 1. Changes of white blood cells, 2. % of blast cells 3. Type of blast cells (myeloblast or lymphoblast etc) 4. morphologic feature (auer rods, vacuoles , the size of the nucleus etc)
  • 13. 2-A bone marrow examination • mostly has hypercellular B.M and few cases hypocellular • 20% to 90% leukemic blasts at diagnosis or during relapse. • The blast must present in the peripheral blood, unless the WBC count is markedly decreased. Acute leukemia Bone Marrow Tryphine Biopsy It is a histological test for bone marrow tissue to obtain the blood cells Indication: If the peripheral blood indicate 1-hypocelluar 2-aplastic anemia 3-metastic cancer Or the previous result indicate  Dry tap bone marrow aspiration
  • 14. 3-Flow cytometry or immunophenotypic studies Monoclonal antibodies toward cell-type restricted antigens are used in this highly specific method CD markers Show for 1. blast cells 2. mature cells and determine if it is 1. myeloid Cells types and count 2. lymphoid cells types and count 3. Normal or abnormal
  • 15. 4- Chromosomal analysis Chromosomal abnormalities studies is very important (diagnostic and prognostic ) for • AML • ALL critical in the diagnosis and treatment of AML.As in ALL Note 1-AML: Acute myeloblastic Leukemia 2-ALL: Acute Lymphoblastic Leukemia
  • 16. 5-Cytochemical stains Importance: very helpful in the diagnosis and classification of acute leukemias Specimens: bone marrow smears but may also be done on peripheral smears 1. myeloperoxidase (MPO) 2. Sudan black B stain (SBB) 3. specific esterase stain (SE) 4. a non specific esterase stain (NSE) 5. Terminal deoxynucleotidyl transferase (TdT) Types
  • 17. Cytochemical Reaction Cellular Element Stained Blasts Identified Myeloperoxidase (MPO) Neutrophil primary granules Myeloblasts strong positive; Sudan Black B (SBB) Phospholipids Myeloblasts strong positive; Specific esterase Cellular enzyme Myeloblasts strong positive; Nonspecific esterase (NSE) Cellular enzyme Monoblasts strong positive Terminal deoxynucleotidyl transferase (TdT) Intranuclear enzyme Lymphoblasts positive
  • 19. Positive-Chloracetate (Specific) Esterase-Myeloid Cell Line Red deposit Brown deposits Positive-Non-Specific Esterase Monocytic Line
  • 20. Leukocyte Alkaline Phosphatase (LAP, Neutrophil Alkaline Phosphatase, NAP) Definition: The LAP score is a test done by performing a chemical reaction on a blood smear Evaluation: 1. The blood smear is viewed under a microscope, and the degree of granular staining in mature neutrophils (bands and segs) is graded from 0 (no staining) to 4+ (dense granular staining). 2. The LAP score is the sum of staining for 100 cells. 3. The normal range is 20 to 100. Principle: The granular of bands and segs with the alkaline phosphatase enzyme colored staining.
  • 21. LAP Score • Count 100 consecutive segs and bands • Score: 0 = no granules 1+ = occasional diffuse granules 2+ = moderate number of granules 3+ = many strongly positive granules 4+ = confluent strongly positive granules Example: 0 x 35 cells = 0 1+ x 30 cells = 30 2+ x 20 cells = 40 3+ x 10 cells = 30 4+ x 5 cells = 20 120 LAP Score
  • 23. The two main conditions with a low LAP score are 1. CML 2. paroxysmal nocturnal hemoglobinuria (PNH). higher scores in 1. Polycythemia vera. 2. Myelofibrosis 3. Essential thrombocytopenia 4. leukemoid reactions LAP score and related diseases Precuations 1. Reject specimens collected in EDTA-anticoagulated (lavender-topped) tubes because EDTA inhibits the activity of LAP 2. Results are invalid if the client is neutropenic (that is, <1000/mm3 neutrophils).
  • 24. Instrumentation and leukemia Platelets The platelets count increased due to fragments of the leukemic blasts, which are counted as platelets To solve this problem 1. Platelets must be counted manually 2. Examination of a blood smear gives a more accurate assessment of the platelet count in this circumstance.
  • 25. Instrumentation and leukemia WBC Must check 1-The count on the blood smear 2-the DLC, if not agree count to 200 cells , report the average Be carful for 1-the clot , old . Lipemic specimen, affects the results of CBC 2-the age of the patient (infant, child, adult) must be taken into account 3- newborns, toddlers, and young children, particular reference ranges must be taken into account 4- a normal range is given, covering 95% of the values of healthy persons 5-The presence of abnormal cells needs clinical pathologist